Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Global Inc Regulatory News (CMPI)

Share Price Information for Ct Global Inc (CMPI)

Share Price is delayed by 15 minutes
Get Live Data
132.50    0.00 (0.00%)
Bid:
130.00
Ask:
135.00
Spread: 5.00 (3.846%)
Market Cap: £125.89m
CMPI Live PriceLast checked at - London Stock Exchange

Intraday Ct Global Inc Share Chart

Result of AGM

1 Oct 2025 16:14

RNS Number : 6960B
CT Global Managed Portfolio - CMPI
01 October 2025
 

To: RNS

Date: 1 October 2025

Company: CT Global Managed Portfolio Trust PLC

LEI: 213800ZA6TW45NM9YY31

 

Subject: Result of Annual General Meeting

 

CT Global Managed Portfolio Trust PLC (the "Company") announces that, at the Annual General Meeting held on 1 October 2025, a poll was held on each of the resolutions and all 15 resolutions proposed were duly passed, including those detailed below:

 

· An ordinary resolution authorising the Directors' to allot new Income shares up to an aggregate nominal amount of £501,584.28 (which equates to 10,873,000 Income shares) and allot new Growth shares up to an aggregate nominal amount of £310,462.82 (which equates to 6,730,000 Growth shares), being approximately 20% of the Company's total issued Income shares and approximately 20% of the Company's total issued Growth shares respectively (excluding shares held in treasury) as at 24 July 2025. This authority will expire at the conclusion of the Company's next Annual General Meeting to be held after the passing of this resolution or on the expiry of 15 months from the passing of this resolution, whichever is earlier, unless previously revoked, varied or extended by the Company in general meeting.

 

· A special resolution authorising the Directors' to allot new Income shares, or resell Income shares held in treasury, up to an aggregate nominal amount of £250,792.14 (which equates to 5,436,500 Income shares) and allot new Growth shares or resell Growth shares held in treasury, up to an aggregate nominal amount of £155,231.41 (which equates to 3,365,000 Growth shares) being approximately 10% of the Company's total issued Income shares and approximately 10% of the Company's total issued Growth shares respectively (excluding shares held in treasury) as at 24 July 2025 for cash without first offering such shares to existing shareholders pro rata to their existing holdings. This authority will expire at the conclusion of the Company's next Annual General Meeting to be held after the passing of this resolution or on the expiry of 15 months from the passing of this resolution, whichever is earlier unless previously varied, revoked or renewed by the Company in general meeting.

 

· A special resolution providing the Directors' with additional authority to allot further new Income shares or resell Income shares held in treasury up to an aggregate nominal amount of £250,792.14 (which equates to 5,436,500 Income shares) and allot further new Growth shares or resell Growth shares held in treasury, up to an aggregate nominal amount of £155,231.41 (which equates to 3,365,000 Growth shares) being approximately 10% of the Company's total issued Income shares and approximately 10% of the Company's total issued Growth shares respectively (excluding shares held in treasury) as at 24 July 2025 for cash without first offering such shares to existing shareholders pro rata to their existing holdings. This authority will expire at the conclusion of the Company's next Annual General Meeting to be held after the passing of this resolution or on the expiry of 15 months from the passing of this resolution, whichever is earlier unless previously varied, revoked or renewed by the Company in general meeting.

 

· A special resolution renewing the Directors' authority to make market purchases of up to 8,149,300 Income shares and 4,978,600 Growth shares being approximately 14.99% of the issued Income shares and 14.99% of the issued Growth shares (excluding Income shares and Growth shares held in treasury). This authority will expire at the conclusion of the Company's next Annual General Meeting or on 1 January 2027, whichever is the earlier, unless previously varied, revoked or renewed by the Company in general meeting.

 

· A special resolution to approve the proposed Purchase Contract to enable the Company to make off-market purchases of its own deferred shares.

 

· An ordinary resolution that the aggregate limit, contained within the Company's articles of association for directors' fees, that the directors may be paid be increased from £150,000 per annum to £175,000 per annum.

 

 

 The results of the poll were as follows:

 

For

Against

Withheld

Total Votes (excluding Votes Withheld)

Resolution

No of Votes

% of Votes Cast

No of Votes

% of Votes Cast

No of Votes

1

Receive & adopt the audited financial statements for the year ended 31 May 2025

41,214,310

99.99

4,337

0.01

2,318,998

41,218,647

2

Receive, adopt & approve Directors' Remuneration Report for the year ended 31 May 2025

37,498,397

94.05

2,373,529

5.95

3,665,717

39,871,926

3

To re-elect Shauna L. Bevan as a Director

38,760,747

95.84

1,682,113

4.16

3,094,782

40,442,860

4

To re-elect Sue P. Inglis as a Director

38,611,255

95.83

1,682,113

4.17

3,244,274

40,293,368

5

To re-elect Simon M. Longfellow as a Director

39,054,295

96.57

1,386,821

3.43

3,096,527

40,441,116

6

To re-elect David Warnock as a Director

38,791,638

96.55

1,385,238

3.45

3,360,767

40,176,876

7

To re-appoint BDO LLP as Auditor

38,705,395

96.14

1,554,614

3.86

3,277,634

40,260,009

8

To authorise the Directors to determine remuneration of the Auditor

40,087,851

98.04

803,510

1.96

2,646,282

40,891,361

9

Approval of the Company's dividend policy

40,770,619

99.29

292,965

0.71

2,474,061

41,063,584

10

Authorise the Directors to allot shares

39,213,832

96.88

1,262,477

3.12

3,061,334

40,476,309

11

Power to allot shares and sell treasury shares without pre-emption rights

36,326,667

92.40

2,989,598

7.60

4,221,377

39,316,265

12

Additional power to allot shares and sell treasury shares without pre-emption rights

35,251,779

89.60

4,093,266

10.40

4,192,597

39,345,045

13

Authority to buy back shares

40,556,583

98.73

522,409

1.27

2,458,652

41,078,992

14

Approval of proposed Purchase Contract

37,441,578

 

 

96.05

1,539,231

3.95

4,556,833

38,980,809

15

That the aggregate limit, in the Company's Articles for directors' fees, be increased to £175,000 p.a.

31,233,649

84.62

5,675,512

15.38

6,628,478

36,909,161

 

 

The full text of all the resolutions can be found in the Notice of Annual General Meeting set out in the Annual Report and Financial Statements for the year ended 31 May 2025 which is available for viewing at the FCA's National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website www.ctglobalmanagedportfolio.co.uk

 

A copy of the poll results will also be available on the Company's website.

 

Under the Articles of Association, at a general meeting on a poll, each Income shareholder and each Growth shareholder is entitled to a weighted vote determined in accordance with the underlying NAV of the relevant share class. The related share voting numbers for this meeting were 1.18 and 2.82 for the Income shares and Growth shares respectively.

 

At the time for the meeting the Company's issued share capital (excluding treasury shares) consisted of 54,540,518 Income shares and 33,213,161 Growth shares with voting rights. Based on the share voting numbers determined for this meeting, the total voting rights applicable to the poll on the above resolutions were 158,018,925.

 

 

 

For further information please contact:

 

Columbia Threadneedle Investment Business Limited

Company Secretary

Telephone: 0131 573 8316

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFSSFIFEISEFS
Date   Source Headline
23rd Jun 202612:45 pmRNSNet Asset Value(s)
22nd Jun 20265:53 pmRNSIssue of Equity
22nd Jun 202612:42 pmRNSNet Asset Value(s)
19th Jun 202612:53 pmRNSNet Asset Value(s)
18th Jun 20262:06 pmRNSPortfolio Update
18th Jun 202612:34 pmRNSNet Asset Value(s)
17th Jun 20264:21 pmRNSNet Asset Value(s)
16th Jun 202612:40 pmRNSNet Asset Value(s)
15th Jun 20261:03 pmRNSNet Asset Value(s)
12th Jun 202612:30 pmRNSNet Asset Value(s)
11th Jun 202612:50 pmRNSNet Asset Value(s)
10th Jun 202612:35 pmRNSNet Asset Value(s)
9th Jun 202612:32 pmRNSNet Asset Value(s)
8th Jun 20264:42 pmRNSIssue of Equity
8th Jun 202612:36 pmRNSNet Asset Value(s)
5th Jun 20261:01 pmRNSNet Asset Value(s)
5th Jun 202612:24 pmRNSPortfolio Update
4th Jun 20263:04 pmRNSDividend Declaration
4th Jun 202612:32 pmRNSNet Asset Value(s)
3rd Jun 202612:39 pmRNSNet Asset Value(s)
2nd Jun 202612:48 pmRNSNet Asset Value(s)
1st Jun 20263:15 pmRNSCompliance with Market Abuse Regulation
1st Jun 202612:44 pmRNSNet Asset Value(s)
1st Jun 202611:07 amRNSTotal Voting Rights
29th May 20265:39 pmRNSTransaction in Own Shares and Issue of Equity
29th May 202612:43 pmRNSNet Asset Value(s)
28th May 202612:50 pmRNSNet Asset Value(s)
27th May 202612:50 pmRNSNet Asset Value(s)
26th May 202612:47 pmRNSNet Asset Value(s)
22nd May 20264:00 pmRNSIssue of Equity
22nd May 20261:37 pmRNSPortfolio Update
22nd May 202612:53 pmRNSNet Asset Value(s)
21st May 202612:54 pmRNSNet Asset Value(s)
20th May 202612:49 pmRNSNet Asset Value(s)
19th May 202612:48 pmRNSNet Asset Value(s)
18th May 20261:47 pmRNSNet Asset Value(s)
15th May 202612:50 pmRNSNet Asset Value(s)
14th May 20265:03 pmRNSIssue of Equity
14th May 202612:47 pmRNSNet Asset Value(s)
13th May 202612:32 pmRNSNet Asset Value(s)
12th May 202612:46 pmRNSNet Asset Value(s)
11th May 20261:13 pmRNSNet Asset Value(s)
8th May 202612:53 pmRNSNet Asset Value(s)
7th May 20265:17 pmRNSTransaction in Own Shares
7th May 202612:42 pmRNSNet Asset Value(s)
6th May 202612:52 pmRNSNet Asset Value(s)
5th May 202612:54 pmRNSNet Asset Value(s)
1st May 20261:00 pmRNSNet Asset Value(s)
1st May 202611:19 amRNSTotal Voting Rights
30th Apr 20263:59 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.